Clarapath: Funding, Investors & Team (Sep 2026)
Clarapath is a medical robotics company that aims to automate laboratory processes. Their initial product focuses on automating the microtomy station in pathology. The company's goal is to revolutionize the field of anatomic pathology by improving lab medicine, enhancing safety standards, increasing lab efficiency, and reducing costs and delays. Their advanced laboratory at the NY Genome Center, along with their image repository and analysis platform, can handle all steps in the tissue processing pipeline for research and clinical purposes. Clarapath collaborates with both research and clinical partners to deliver quicker and more precise outcomes.
Clarapath has raised $36.0M across 1 funding round on record, the most recent a Series B of $36.0M announced in Jul 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Clarapath Company Profile and Key Stats
Latest funding round on record: Jul 2024.
Clarapath Funding Rounds
Clarapath Founders and Leadership Team
Contact details for the Clarapath team: 1 of 1 has an email address on file.
Start 14-day free trial →Clarapath Funding Compared to Other Biotechnology Startups
Clarapath's latest round of $36.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Clarapath in Biotechnology and New York
Companies Similar to Clarapath
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Clarapath Funding FAQs
What does Clarapath do?
Clarapath is a medical robotics company that aims to automate laboratory processes. Their initial product focuses on automating the microtomy station in pathology. The company's goal is to revolutionize the field of anatomic pathology by improving lab medicine, enhancing safety standards, increasing lab efficiency, and reducing costs and delays. Their advanced laboratory at the NY Genome Center, along with their image repository and analysis platform, can handle all steps in the tissue processing pipeline for research and clinical purposes. Clarapath collaborates with both research and clinical partners to deliver quicker and more precise outcomes.
How much funding has Clarapath raised?
Clarapath has raised $36.0M across 1 round on record. The most recent is a Series B of $36.0M announced in Jul 2024.
When did Clarapath last raise funding?
Clarapath's most recent funding round on record is a Series B of $36.0M, announced in Jul 2024.
Who founded Clarapath?
FundedIQ lists Partha Mitra (Founder) at Clarapath.
Where is Clarapath headquartered?
Clarapath is based in New York, United States.
How many employees does Clarapath have?
Clarapath is in the 11-50 employee band.
How does Clarapath's funding compare to other Biotechnology startups?
Clarapath's latest round of $36.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Clarapath Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Clarapath is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.